Basel, 18 September 2018
Reminder: Invitation to Roche’s Virtual Pipeline Event: Key data for Roche’s lung cancer portfolio to be presented at the 2018 IASLC World Conference on Lung Cancer
Agenda
- Roche lung cancer portfolio key data
IMpower133: Primary PFS, OS, and Safety in a Ph1/3 Study of 1L Atezolizumab + Carboplatin + Etoposide in extensive-stage SCLC
IMpower132: PFS, OS and Safety Results of 1L Atezolizumab + Carboplatin/Cisplatin + Pemetrexed in Stage IV Non-Squamous NSCLC
Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive NSCLC
- Roche Lung Cancer program overview
- Q&A
Speakers include Alan Sandler, Global Head Pharma Development Oncology, and Sushil Patel, Franchise Head, Lung & Rare Cancers, Global Product Strategy.
To join the live webcast or to dial in, please follow instructions as outlined below:
Tuesday, 25 September 2018
- 17:00 – 18:00 CEST / 16:00 – 17:00 BST
- 11:00 am – 12:00 pm EDT / 08:00 am – 09:00 am PDT
Live audio webcast and conference call will start with presentations by senior management followed by a Q&A session (questions can be asked via phone and webcast).
The live audio webcast can be accessed via ir.roche.com.
In order to receive your personal dial-in details and expedite your access to the conference call, please pre-register under this link.
If you have not pre-registered, please find the dial-in numbers below, we recommend you to dial in to the conference 10-15 min prior to the scheduled start.
+41 (0) 58 310 5000 (Europe and ROW)
+44 (0) 207 107 0613 (UK)
+1 (1) 631 570 5613 (USA Toll Free)
Presentation slides and a replay of the webcast will be available via ir.roche.com